23/10/2013 Announcement:CEO Presentation to 2013 AGM clearly states the potential of a capital raising pg21. It also notes cohort four had begun pg6
11/11/2013 Announcement:Patrys to initiate an Investigator-Sponsored Clinical Trial using PAT-SM6 in combination with Onyx Pharmaceuticals’ carfilzomib.
29/11/13 Announcement:Data from Final Cohort of Patients in Multiple Myeloma Clinical Trial
11/12/2013 or perhaps a day or two earlier an interim report with results from Onyx Pharmaceuticals’??? Maybe.
If a successful interim report from Onyx Pharmaceuticals’ trial is published prior to the close of the rights issue I'd suggest someone has given these last few weeks a great deal of consideration.
How many lawyer hours would 12.5 million cover?? Any deal with any company/ies would have three or four jurisdictions to cover
just some scattered thoughts on my part
PAB Price at posting:
5.2¢ Sentiment: None Disclosure: Not Held
